AI assistant
DIRECTA PLUS PLC — Board/Management Information 2020
Jul 28, 2020
7601_mang_2020-07-28_151be27c-86cc-4d7d-8278-b562ba3036ef.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 2198U
Directa Plus PLC
28 July 2020
28 July 2020
Directa Plus plc
("Directa Plus" or the "Company")
Appointment of Nominated Adviser and Joint Broker
Directa Plus plc (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that it has appointed Cenkos Securities plc as Nominated Adviser and Joint Broker with immediate effect.
For further information please visit http://www.directa-plus.com/ or contact:
| Directa Plus plc Giulio Cesareo, CEO Marco Ferrari, CFO |
Tel: +39 02 36714458 |
| Cenkos Securities plc (Nomad & Joint Broker) Neil McDonald / Pete Lynch |
Tel: +44 131 220 6939 |
| N+1 Singer (Joint Broker) | Tel: +44 20 7496 3069 |
| Mark Taylor | |
| Tavistock (Financial PR and IR) | Tel: +44 20 7920 3150 |
| Simon Hudson / Edward Lee |
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
APPQDLFLBDLXBBZ